Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

Clinical trial NCT01671956 · TERMINATED

Trial details

NCT number: NCT01671956
Sponsor: Alexion Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis, Active Moderate Ulcerative Colitis, Active Severe

Start date: 2015-07-31
Primary completion: 2018-08-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.